Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Golden Heights voluntary redemption of its outstanding bond 2019/2022

Reference is made to the SEK 400,000,000 Senior Secured Floating Rate Notes 2019/2022 (ISIN: SE0010599498) (the “Notes”) issued by Golden Heights Aktiebolag publ (the “Issuer”) and to the terms and conditions of the Notes (the “Terms and Conditions”). Unless otherwise defined herein, terms used in this notice shall have the same meaning as in the Terms and Conditions. The Issuer has, by way of a call notice dated 23 November 2021 (the “Call Notice”), submitted a conditional notice of exercising its right to redeem in full all outstanding Notes in accordance with Clause 10.3 (Voluntary

Invitation to Climeon's Investor Meeting on December 6, 2021

As communicated in connection with the latest interim report, Climeon will host a digital investor meeting for investors, analysts and the media on Monday, December 6, 2021.The meeting is the first opportunity for Climeon’s newly appointed CEO, Lena Sundquist, to present her view of the company to a wider group of stakeholders. The digital meeting will begin at 9.30 AM (CET) and will be held in English.  Climeon’s CEO, Lena Sundquist, together with Chairman of the Board, Thomas Öström, and Head of R&D, Jonas Måhlen, will update investors, analysts and the media on Climeon’s development

Corem signs Letter of Intent with ALM Equity

Corem and ALM Equity AB have signed a letter of intent to investigate the conditions for creating a joint company, whose purpose is to develop efficient and climate-smart rental housing for own management. The joint company is planned to include both existing investment properties and building rights for future development of an estimated 24,000 homes in the Stockholm area and Mälardalen. The company's goal is to create continued growth and can be expanded to consist of more property owners. The parties intend to list the joint company. ”We see great potential in our building

Divio Technologies AB (publ) has extended an existing contract with MMR USD 3,300

Divio Technologies AB announces today that it has expanded an existing service agreement with a large financial institution. The extended agreement covers the use of our platform in new regions and is expected to generate USD 3,300 in MRR (Monthly Recurring Revenues) with immediate effect. Jon Levin, CEO of Divio Technologies AB said: “This is very much what our strategy is about, you start with a relatively small agreement and then, when you have proven your technology and service, you expand the agreement within the customer's organization. This also shows our strength and that once

UIE's Third Quarter Report 2021

On Tuesday 23 November 2021, UIE Plc. announced its Third Quarter Report 2021. Highlights from Q3 2021: · UIE’s net result in the first nine months of 2021 amounted to USD 79.8 million, which is USD 17.2 million higher than the result of USD 62.6 million reported in the  first nine months of 2020. · UIE’s share of UP’s net profit increased by 24% to USD 42.6 million. UP’s plantation division reported slightly higher production volumes for crude palm oil ("CPO") and palm kernel ("PK"), whilst significantly higher selling prices of CPO and PK led to an improved result compared to

Nurminen Logistics repays a loan of EUR 5 million to Ilmarinen and raises a loan of EUR 3.5 million from Oma SP

Nurminen Logistics Plc          Stock Exchange Release November 23, 2021, at 8.30 a.m. The Board of Directors of Nurminen Logistics Plc [the Company] has decided to prematurely repay a loan of EUR 5 million to Ilmarinen Mutual Pension Insurance Company, which would have matured in June 2023, and to withdraw a long-term loan of EUR 3.5 million from Oma Säästöpankki Oyj.  The loan arrangement reduces the Company's indebtedness and is a significant step in developing the Company's financing capacity for the future.  Nurminen Logistics Plc  For more information, please contact Olli

DBP International AB: Named Patient Early Access Program with Temozolomide gel (Temodex®) has been launched

Double Bond Pharmaceutical International AB (publ) (“DBP” or “Double Bond”) are pleased to announce that as of November 23 they have launched a Named Patient Treatment Access Program for Temozolomide gel (Temodex®) to provide a ground-breaking new treatment paradigm for Glioblastoma patients across the globe prior to global registration. Glioblastoma, the most common and aggressive malignant form of all primary brain tumours, affects glial cells and accounts for 52% of all brain tissue tumour cases and 20% of all tumours inside the skull.  Approximately 250 000 patients with

Skanska signs lease with Telia for their Danish headquarter in the office building Nest45 in Copenhagen, Denmark

Skanska has signed an 8-year lease agreement with Telia for approximately 6,000 square meters in the Nest45 office building in Ørestad City, Copenhagen, Denmark. With this lease the building is now about 90 percent occupied.Telia will move into its new premises in November 2022. The office building is located 50 meters from the nearest metro station and is within cycling distance of Copenhagen. The lease covers approximately 6,000 square meters office and additional 140 underground parking spaces. The project which is under construction is planned for completion during autumn 2022 and

Pagero Group AB (publ) publishes interim report for Q3 2021

Pagero Group AB (publ) publishes interim report for the third quarter (July – September) 2021”An intense quarter with strong growth figures is at an end. We continued our investments in Pagero's newly established markets outside the Nordic region in order to meet the growing global demand. With a completed new share issue at the beginning of the last quarter of 2021, we raised SEK 465 million in capital and Pagero is now well equipped organizationally, financially and in terms of products to deliver according to our growth plan”, says Bengt Nilsson, CEO at Pagero  Third quarter 2021

Bravida strengthens its position in the ventilation market in Jönköping by acquiring Öbergs Vent Teknik AB

Bravida is acquiring the company Öbergs Vent Teknik AB, thereby strengthening its position in the ventilation sector in Jönköping. The company has sales of around SEK 57 million and 22 employees.Öbergs Vent Teknik was founded in 1988 and provides both installation and service in the ventilation sector, as well as special services such as OVK inspections (mandatory ventilation checks). The company is based in the city of Jönköping, and has customers and clients throughout Jönköping County, consisting of both local and national construction companies and municipal housing companies.  “We

NCC to construct 584 apartments in northwest Stockholm

NCC has been commissioned by fund manger Slättö to construct 584 rental apartments in Bromsten in the northwest of Stockholm. The project is a turnkey contract with an order value of approximately SEK 665 million. Image: Erik Mårtensson Situated in northwest Stockholm, Bromsten industrial area will now undergo a transformation into Bromstensstaden. A large area of rental apartments will be constructed here, close to Spånga town centre, transport links and green areas. “I’m delighted to carry out this project together with NCC. Since the very beginning of the project planning

SynAct Pharma reports positive PK data on AP1189 tablets

SynAct Pharma AB ("SynAct") today announced that it has received positive data from the first part of the ongoing pharmacokinetic (PK) study of AP1189 following oral administration of AP1189 tablets to healthy volunteers.Data from a single dose cross-over study in 12 healthy volunteers of dosing of 2 x 50 mg AP1189 Tablets vs 100 mg AP1189 Powder for Suspension (the formulation used in the current clinical phase 2 development program), demonstrates that relevant PK parameters are comparable following dosing tablets and oral suspension. The data supports use of tablets in upcoming clinical

Vestas introduces the V162-6.8 MW, expanding the EnVentus platform’s power output and market applicability

News release from Vestas Wind Systems A/SAarhus, 23 November 2021 Renewables are already a critical component in energy systems across the globe with continued scaling and technology development playing a key role in making renewables the dominant energy source in all parts of the world. To lead the expansion of wind energy and leveraging our modular product development to offer enhanced customisation for medium to high wind sites, Vestas today introduces the V162-6.8 MW wind turbine of the EnVentus platform. The V162-6.8 MW is globally applicable and combines an increased power

YIT increases its result guidance for 2021 due to Lestijärvi wind farm sale and actions based on YIT’s new strategy: Group adjusted operating profit expected to be in the range of EUR 105-125 million

YIT Corporation Insider information 23 November 2021 at 8:00 a.m.YIT increases its result guidance for 2021 due to Lestijärvi wind farm sale and actions based on YIT’s new strategy: Group adjusted operating profit expected to be in the range of EUR 105-125 million YIT increases its result guidance for 2021 due to the realisation of Lestijärvi wind farm sale and actions based on YIT’s new strategy. YIT expects its Group adjusted operating profit to be in the range of EUR 105-125 million in 2021. Earlier YIT expected its full-year 2021 adjusted operating profit to be higher than in 2020 (

Medical technology companies to benefit from Picosun biocompatible materials

ESPOO, Finland, 23 of November 2021 – Picosun Group has launched a Medical Materials Library consisting of over ten materials intended for medical-related coating and encapsulation with Atomic Layer Deposition (ALD). ALD coatings are ultra-thin, and they guarantee hermetic encapsulation of virtually any implanted device. The materials library is a reflection of over six years extensive research and development that shows ALD can render biocompatibility to a substrate coated with Picosun library materials. Biocompatibility tests were carried out according to ISO standards in accredited

Karo Pharma acquires Sylphar International NV for EUR 290m and intends to carry out a rights issue of approximately EUR 200-250m

Karo Pharma Aktiebolag (publ) (the ”Company” or ”Karo”) has today entered into an agreement to acquire all of the shares in Sylphar International NV (“Sylphar”) and, direct and indirect, all of the shares in Pro Teeth Whitening Co Limited (“Pro Teeth Whitening”), Nutravita Limited (“Nutravita”) and Alpha Foods BV (“Alpha Foods”, together the “Sylphar Group”) from Vendis Capital and Robin List, Sylphar’s founder, for EUR 290m (the ”Transaction”). The Transaction is expected to contribute positively to Karo’s market position and further enhance Karo’s strong platform for continued growth,

Lundin Mining Provides Operational Outlook & Update

Toronto, November 22, 2021 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) provides the following production guidance for the three-year period of 2022 through 2024, as well as cash cost, capital and exploration expenditure forecasts for 2022. The Company will hold a conference call and webcast on Tuesday November 23, 2021, to answer investor and analyst questions. Additionally, the Company announces renewal of its Normal Course Issuer Bid (“NCIB”), pending final approvals. (This news release contains non-GAAP measures and forward-

Nilar reduces workforce in Gävle and Täby, Sweden

Täby, November 22 2021. Nilar International AB’s subsidiary Nilar AB announces today that two notices of dismissal have been issued, among collective agreement employees and white-collar employees in Gävle and white-collar employees in Täby. The notice will affect 110 employees. Negotiations with trade unions will be initiated.The background to the notice is a need to temporarily slow down the business. As previously announced, both Nilar and Nilar's partners have had major difficulties with the purchase of electronic components, which has had a significant effect on sales for the period.

NILAR INTERIM REPORT Q3 2021

SHORT-TERM CHALLENGES WILL BE OVERCOME WITH NILAR’S FUNDAMENTAL STRENGTHJuly – September 2021 in summary · Net sales, MSEK 5.4 (7.5). · Production MWh 4.2 (1.6). · Delivered energy storage 196 (159), average size per energy storage 7 (9) kWh. · Gross profit MSEK -87.4 (-39.9). · EBITDA MWh -93.0 (-42.6). · Operating profit (EBIT) MSEK -112.2 (-58.3). · Profit for the period MSEK -100,0 (-75.6). · Earnings per share before/after dilution SEK -2.20. January – September 2021 in summary · Net sales, MSEK 17.9 (19.6). · Production MWh 10.7 (5.5). ·

Nordea Bank Abp: Repurchase of own shares on 22.11.2021

Nordea Bank AbpStock exchange release – Changes in company’s own shares22.11.2021 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 22.11.2021 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR*Code) shares **XSTO 305,684 10.85 3,315,205.37XHEL 286,504 10.85 3,107,766.19CEUX 171,381 10.85 1,859,034.95AQEU 12,735 10.86 138,321.95TQEX

Exercise of Employee Share Options

Pexip Holding ASA ("Pexip" or "The Company", Oslo Børs Ticker: PEXIP) has been notified that participants in the Company’s option program have on November 22, 2021, exercised 231,412 options with an average strike price of NOK 24.68 per share. Following the exercise, 231,412 shares will be transferred from the Company’s holding of own shares. After the transaction, Pexip Holding ASA holds 900,205 own shares. Options exercised by primary insiders: Øystein Hem (Interim CEO and CFO) has exercised 7,500 options in the Company, corresponding to 7,500 shares at the strike price of NOK 25.00.

Scandion Oncology announces share purchase by Board of Directors and Executive Management

Scandion Oncology A/S, the Cancer Drug Resistance Company, today announced that members of the Board of Directors and Executive Management have purchased shares in the company.The following share purchases have been reported: Shares purchased Total shareholding Peter Chairman of the Board 6,500 59,565HøngaardAndersenJørgen Vice-chairman of the Board 15,000 425,629BardenflethChristian Board member 10,000 10,000VindingThomsen

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 22.11.2021

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 22.11.2021 at 18:30 EET ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 22.11.2021 Date 22.11.2021Exchange transaction BuyShare class ALEXAmount 195Average price/share 8.3500 EURHighest price/share 8.3500 EURLowest price/share 8.3500 EURTotal price 1,628.25 EUR The shares held by Alexandria Pankkiiriliike Oyj on 22.11.2021: ALEX 39,913 On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (Publ)

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 22.11.2021

United Bankers Corporation NOTIFICATION 22.11.2021 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 22.11.2021 Date 22.11.2021Exchange transaction BuyShare class UNITEDAmount 303Average price/share 13.5000 EURHighest price/share 13.5000 EURLowest price/share 13.5000 EURTotal price 4090.50 EUR The shares held by United Bankers Corporation on 22.11.2021: UNITED 52,680 On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka

There are no items matching the current filter
There are no more items matching the current filter
Back to top